Doctor Faces Up to Three Years in Prison for Administering Non-FDA-Approved Semaglutide to Patients

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Doctor Faces Up to Three Years in Prison for Administering Non-FDA-Approved Semaglutide to Patients

Dennis Tosh

April 30, 2025 at 02:20 PM EST

A Kentucky physician has pleaded guilty to a felony misbranding charge in connection with his purchase of non-FDA-approved semaglutide that was administered to his patients at a weight loss clinic (United States v. Lewis, No. 0:25-cr-00004-DLB (E.D. Ky.)). Dr. Matthew Lewis, the owner of Lewis Family Care in Ashland, Kentucky, pleaded guilty in the U.S. District Court for the... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Doctor Faces Up to Three Years in Prison for Administering Non-FDA-Approved Semaglutide to Patients

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT